Abstract
The role of sentinel node biopsy in breast cancer has increased over the last few years. Sentinel nodes can predict the status of all axillary lymph nodes precisely and select patients with negative nodes for whom axillary dissection is unnecessary. Many problems remain, such as the ideal injection technique, ideal agents, and ideal histological detection of sentinel node metastases, and must be addressed before sentinel node biopsy becomes the standard of care for patients with breast cancer.
Similar content being viewed by others
References
Fisher B, Redmond C, Fisher ER,et al: Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with and without irradiation.N Engl J Med 312: 674–681, 1985.
Haagensen C: The surgical treatment of mammary carcinoma. In: Disease of the Breast, 2nd ed, WB Saunders, Philadelphia, pp704–709, 1971.
Nieweg OE, Tanis PJ, and Kroon BBR: The definition of a sentinel node.Ann Surg Oncol 8: 538–541, 2001.
Krag DN, Weaver DL, Alex JC, and Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.Surg Oncol 2: 335–339, 1993.
Giuliano AE, Kirgan DM, Guenther JM, and Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann Surg 220: 391–401, 1994.
Giuliano AE, Jones RC, Brennan M, and Statman R: Sentinel lymphadenectomy in breast cancer.J Clin Oncol 15: 2345–2350, 1997.
Motomura K, Inaji H, Komoike Y,et al: Sentinel node biopsy in breast cancer patients with clinically negative lymph-nodes.Breast Cancer 6: 259–262, 1999.
Krag D, Weaver D, Ashikaga T,et al: The sentinel node in breast cancer-A multicenter validation study.N Engl J Med 339: 941–946, 1998.
Veronesi U, Paganelli G, Galimberti V,et al: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.Lancet 349: 1864–1867, 1997.
Albertini JJ, Lyman GH, Cox C,et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.JAMA 276: 1818–1822, 1996.
Cox CE, Pendas S, Cox JM,et al: Guidlines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.Ann Surg 227: 645–653, 1998.
Tafra L, Lannin DR, Swanson MS,et al: Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye.Ann Surg 233: 51–59, 2001.
Zervos EE, and Burak WE Jr: Lymphatic mapping for breast cancer: Experience at the Ohio State University.Breast Cancer 7: 195–200, 2000.
McMasters KM, Tuttle TM, Carlson DJ,et al: Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.J Clin Oncol 18: 2560–2566, 2000.
Motomura K, Inaji H, Komoike Y,et al: Combination technique is superior to dye alone in identification of the sentinel node in breast cancer.J Surg Oncol 76: 95–99, 2001.
Takayama S, Furuhama K, Ohura K,et al: Experimental studies on the usefulness of indocyanine green (ICG) as a lymphatic vital dye.Ohyo Yakuri 19: 603–614, 1980 (in Japanese).
Nieweg OE, Jansen L, Olmos RAV,et al: Lymphatic mapping and sentinel lymph node biopsy in breast cancer.Eur J Nucl Med 26(Suppl): Sll-S16, 1999.
Linehan DC, Hill ADK, Tran KN,et al: Sentinel lymph node biopsy in breast cancer: Unfiltered radioisotope is superior to filtered.J Am Coll Surg 188: 377–381, 1999.
Paganelli G, De Cicco C, Cremonesi M,et al: Optimized sentinel node scintigraphy in breast cancer.Q J Nucl Med 42: 49–53, 1998.
Cox CE, Bass SS, and Reintgen DS: Techniques for lymphatic mapping in breast carcinoma.Surgical Oncology Clinics of North America 8: 447–468, 1999.
Motomura K, Inaji H, Komoike Y,et al: Sentinel node biopsy guided by indocyanin green dye in breast cancer patients.Jpn J of Clin Oncol 29: 604–607, 1999.
Motomura K, Komoike Y, Inaji H,et al: Patient age affects identification rate of sentinel nodes in breast cancer.Biomed Pharmacother (in press).
Cody HS 3rd, Fey J, Akhurst T,et al: Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures.Ann Surg Oncol 8: 13–19, 2001.
Motomura K, Inaji H, Komoike Y,et al: Gamma probe and ultrasonographically-guided fine-needle aspiration biopsy of sentinel lymph nodes in breast cancer patients.Eur J Surg Oncol 27: 141–145, 2001.
Rubio IT, Korourian S, Cowan C,et al: Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer.Ann Surg Oncol 5: 689–694, 1998.
Ratanawichitrasin A, Biscotti CV, Levy L, and Crowe JP: Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer.Br J Surg 86: 1346–1349, 1999.
Henry-Tillman RS, Korourian S, Rubio IT,et al: Intraoperative touch preparation for sentinel lymph node biopsy: a 4-year experience.Ann Surg Oncol 9: 333–339, 2002.
Motomura K, Inaji H, Komoike Y,et al: Intraoperative sentinel lymph node examination by imprint cytology and frozen section during breast surgery.Br J Surg 87: 597–601, 2000.
Veronesi U, Paganelli G, Viale G,et al: Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series,J Natl Cancer Inst 91: 363–373, 1999.
International (Ludwig) Breast Cancer Study Group: Prognostic importance of occult axillary lymph node micrometastases from breast cancers.Lancet 335: 1565–1568, 1990.
Giuliano AE, Dale PS, Turner RR,et al: Improved axillary staging of breast cancer with sentinel lymphadenectomy.Ann Surg 222: 394–401, 1995.
Motomura K, Komoike Y, Inaji H,et al: Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer.Br J Surg 89: 1032–1034, 2002.
Author information
Authors and Affiliations
Corresponding author
Additional information
Reprint requests to Kazuyoshi Motomura, Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka 537-8511, Japan.
About this article
Cite this article
Motomura, K., Komoike, Y., Nagumo, S. et al. Sentinel node biopsy to avoid axillary lymph node dissection in breast cancer. Breast Cancer 9, 337–343 (2002). https://doi.org/10.1007/BF02967614
Issue Date:
DOI: https://doi.org/10.1007/BF02967614